“We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but preliminary efficacy data as the study progresses,” said Dr. Huma Qamar, Chief ...
Breakthroughs in age-related macular degeneration (AMD) treatments have revolutionized the management of this progressive and potentially devastating eye disease. These include treatments such as ...
Age-related macular degeneration (AMD) is the leading cause of vision loss for people over 65. We have excellent treatments for the wet form of AMD. But until recently, we haven’t had any ...
and genetic therapies used in wet age-related macular degeneration (AMD). These therapies aid in overcoming problems with current therapies as well as tackling age-related diseases. Heart valves ...
Innovations include stem cells being used in the treatment of Parkinson’s disease, a heart valve capable of growing in vivo, and genetic therapies used in wet age-related macular degeneration ...